AOD-9604 vs BPC-157
Updated November 4, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of AOD-9604 and BPC-157 (also searched as BPC-157 vs AOD-9604) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
AOD-9604 centers on skin, while BPC-157 leans toward healing. On indexed research, BPC-157 is ahead (AOD-9604: 12 studies, Human evidence; BPC-157: 16, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •AOD-9604 is strongest for skin; BPC-157 for healing.
- •Evidence: AOD-9604 Human evidence (12 studies) vs BPC-157 Human evidence (16).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
AOD-9604 vs BPC-157: side-by-side
| Metric | AOD-9604 | BPC-157 |
|---|---|---|
| Class | Metabolic | Healing |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Human evidence | Human evidence |
| Studies indexed | 12 | 16 |
| Research level | Limited Research | Preclinical |
| Strongest effect | Skin & aesthetics | Healing & recovery |
| Healing & recovery | 2.0 | 4.0▲ |
| Muscle & body comp | 1.0 | 3.0▲ |
| Metabolic & appetite | 3.0▲ | 2.0 |
| Neuro & mood | 0.0 | 2.0▲ |
| Sleep & circadian | 0.0 | 1.0▲ |
| Inflammation & immune | 1.0 | 4.0▲ |
| Skin & aesthetics | 3.0▲ | 1.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | AOD-9604 | BPC-157 |
|---|---|---|
| Mechanism | Modified hGH fragment (176–191) | Body-protective compound (pentadecapeptide); cytoprotective, pro-angiogenic signaling |
| Route | Subcutaneous injection (research use) | Subcutaneous / oral (research use) |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is AOD-9604?
A GH-fragment–derived peptide primarily discussed for fat loss and body-composition change, sometimes with cartilage and joint-repair context.
Full AOD-9604 profile, mechanism & studies →What is BPC-157?
BPC-157, or Body Protective Compound-157, is a synthetic peptide derived from a protein found in human gastric juice. It has attracted attention for its potential roles in soft-tissue repair, gastrointestinal (GI) support, and the modulation of inflammation. The peptide is believed to exert its effects through several mechanisms, including the promotion of angiogenesis, modulation of growth factors, and reduction of oxidative stress and inflammation.
Full BPC-157 profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | BPC-157 | 4.0/5 effect signal |
| Muscle | BPC-157 | 3.0/5 effect signal |
| Metabolic | AOD-9604 | 3.0/5 effect signal |
| Neuro | BPC-157 | 2.0/5 effect signal |
| Sleep | BPC-157 | 1.0/5 effect signal |
| Inflammation | BPC-157 | 4.0/5 effect signal |
| Skin | AOD-9604 | 3.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack AOD-9604 and BPC-157?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
AOD-9604 vs BPC-157: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
AOD-9604 has 12 approved studies indexed (Human evidence), and BPC-157 has 16 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is AOD-9604 or BPC-157 better?
It depends on your goal. AOD-9604 is strongest for skin; BPC-157 for healing. BPC-157 has more indexed studies (16). See the goal-by-goal breakdown above.
Is AOD-9604 or BPC-157 better for weight loss?
AOD-9604 shows the stronger metabolic & appetite profile (3.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is AOD-9604 or BPC-157 better for muscle?
BPC-157 leads on the muscle & body-composition axis (3.0/5).
Which has more research, AOD-9604 or BPC-157?
AOD-9604 has 12 approved studies indexed (Human evidence); BPC-157 has 16 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack AOD-9604 and BPC-157?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of AOD-9604 vs BPC-157?
AOD-9604: no community-reported effects logged yet. BPC-157: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is AOD-9604 or BPC-157 FDA-approved?
AOD-9604 is a research-use compound and is not FDA-approved. BPC-157 is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is BPC-157 better than AOD-9604?
For healing, BPC-157 has the edge; for skin, AOD-9604 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
AOD-9604 and BPC-157 are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed November 4, 2026.